News Headlines Article

Inspector general sees savings in drug-price substitution policy
Modern Healthcare

Medicare would have saved about $7 million in 2011 if a long-awaited CMS drug-price substitution policy had been in effect, a government watchdog concluded. In the HHS Office of the Inspector General’s latest analysis of the differences between average sales prices for medications covered by Medicare Part B and the average manufacturer prices for those pharmaceuticals in 2011, it found at least a 5% difference among 58 types of drugs. That difference cost the program $14.4 million in 2011, according to the analysis.